JRoon, Changes on the board have occurred. Dr. Denner orchestrating those changes is an assumption. That is just step 1 in the daisy chain that brought you to your conclusion. After that you gave your opinion about what you thought Dr. Denner was currently thinking. We have no idea what Denner is thinking. At the end of it all you presented a theory that a company, with a connection to one of our new board members, would take Amarin private at a low ball price. That conclusion doesn't make much sense. Not when you consider the average share price of Dr. Denner's investment.
Sleven,
Market Data 
Markets 
AI
